Therapeutic Investability: Who Shall Be Invited to Dance?

Please Register Here: https://www.sginnovate.com/events/therapeutic-investability-who-shall-be-invited-dance

Therapeutic Investability: Who Shall Be Invited to Dance?

Presented by SGInnovate and Eureka Institute for Translational Medicine
Partnered with SingHealth-DukeNUS Academic Medical Centre

In the first half of 2019, the total new money entering the Asia Pacific HealthTech sector was US$2.5 billion across 140 deals. And the second quarter of 2019 was the 8th consecutive $1 billion or more quarter for HealthTech in Asia. While the number of deals is going down, the individual deals are getting larger and more likely to be in later-stage companies (Galen Growth Asia 2019 Half Year Asia HealthTech Landscape report).

So how do the dancers choose who to invite to the dance floor in the first place? What makes a startup appealing to an investor, and what makes an investor attractive to the investee?

Join us for a review of the life science investment landscape in Asia, followed by a discussion between venture capitalists and startups.

Please Register Here: https://www.sginnovate.com/events/therapeutic-investability-who-shall-be-invited-dance

Date: 6 February 2020
Time: 4:00pm – 6:00pm
Venue: 32 Carpenter Street, Singapore 059911

Speakers:

Vishal Doshi, CEO & Founder, AUM Biosciences
Lawrence Low, Senior Vice President, EDBI
Kasia Suzor, CEO & Co-Founder, Ardion
Moderator: Prof Salvatore Albani, Professor, Duke-NUS Medical School, Director of Translational Immunology Institute, SingHealth-Duke-NUS Academic Medical Centre and UCAN-A Chair & President, Eureka Institute

Programme Details
4:00pm – 4:30pm: Registration
4:30pm – 5:30pm: Panel Discussion and Q&A
5:30pm – 6:00pm: Networking